Specialty Pharmacy

Combination therapy found to reverse multiple sclerosis in mice models.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Top news of the day from across the healthcare landscape.

Once-daily HIV treatment found to be highly effective and well-tolerated in treating antiretroviral-naïve HIV-1 patients.

The emergence of biosimilars will reduce spending on biologics by 3% through 2027.

Varubi indicated for use in combination with other antiemetic agents to treat delayed chemotherapy-induced nausea and vomiting in adults.

Genome analysis points to potential new treatments for patients with chordoma.

Novel drug causes apoptosis in leukemia cells, while leaving healthy blood cells unscathed.

Top news of the day from across the healthcare landscape.

How pharmacists can reduce polypharmacy and potentially inappropriate prescribing among the aging HIV population.

This paper examines the use and implications of direct and indirect remuneration (DIR) fees and potential strategies to overcome the challenges that accompany DIR fees.

Grant Knowles, PharmD, vice president, Business Development, Ardon Health, discusses the potential impact biosimilars will have in health care.

Hepatitis B virus is known to increase the risk of cirrhosis and hepatocellular carcinoma.

MRIs show brain changes related to multiple sclerosis before symptom onset.

A hepatitis C virus diagnosis may curb drug use among those in treatment.

The mechanisms of BRCA mutations are still largely unknown.

Top news of the day from across the healthcare landscape.

Calcipotriene and betamethasone dipropionate treats mild to moderate plaque psoriasis in adult patients.

Physician and pharmacist collaboration is key within the complex pain management prescribing landscape.

A derivative of a natural compound could stop HIV replication and prevent a viral rebound.

PPARγ agonists may improve outcomes for patients with acute myeloid leukemia.

The presence of certain bacteria could result in worsening of multiple sclerosis.

Top news of the day from across the healthcare landscape.

Two supplemental biologics license applications granted to golimumab to treat adults with psoriatic arthritis and adults with active ankylosing spondylitis.

Dabrafenib (Tafinlar) plus trametinib (Mekinist) improved relapse-free survival for patients with melanoma with a BRAF V600 mutation.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, talks about using medical marijuana for the treatment of specialty conditions.

Fifteen researchers receive more than $22 million for rare disease clinical trials.

Developing a vaccine that launches immune attacks against cancer proves to be difficult.